Neurothera is developing technology and treatment devices for several neurological conditions.
NeuroThera’s newest technology brings a drug-free, pain-free option for treatment of Major Depressive Disorder using photobiomodulation.
Clinical trials are ongoing at Massachusetts General Hospital, Boston and New York University, New York City.
In addition to MDD, Neurothera is developing advanced photobiomodulation technology and devices for the treatment of:
- Alzheimer’s Disease
- Mild Cognitive Impairment
- Parkinson’s Disease
- Traumatic Brain Injury